<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03262909</url>
  </required_header>
  <id_info>
    <org_study_id>CLN-GR-01</org_study_id>
    <nct_id>NCT03262909</nct_id>
  </id_info>
  <brief_title>Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for Treatment of Cartilage Defects</brief_title>
  <acronym>SAGE</acronym>
  <official_title>A Prospective, Open-Label, Multicenter Pivotal Study to Evaluate the Safety and Efficacy of GelrinC® for the Treatment of Symptomatic Articular Cartilage Defects of the Femoral Condyle: A Comparison to Historical Control Microfracture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regentis Biomaterials</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regentis Biomaterials</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicenter, open-label, controlled, non-randomized, double arm trial with a prospective
      treatment arm (GelrinC). This study compares the efficacy and safety of GelrinC to a
      historical control arm (microfracture) in the treatment of cartilage defects in the knee.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2017</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of physical functioning as assessed by patient reported outcome measure (Knee injury and Osteoarthritis Outcome Score (KOOS).</measure>
    <time_frame>24 months post-surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of physical pain as assessed by patient reported outcome measure (Knee injury and Osteoarthritis Outcome Score (KOOS).</measure>
    <time_frame>24 months post-surgery</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">181</enrollment>
  <condition>Articular Cartilage Defects in the Knee Joint</condition>
  <arm_group>
    <arm_group_label>GelrinC prospective treatment arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo GelrinC implantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microfracture historical control arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Microfracture historical control arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GelrinC</intervention_name>
    <description>Patients will undergo GelrinC implantation.</description>
    <arm_group_label>GelrinC prospective treatment arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Microfracture historical control arm</intervention_name>
    <description>Patients undergo an arthroscopy for evaluation purposes, followed by lesion debridement, and a standard microfracture procedure.</description>
    <arm_group_label>Microfracture historical control arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Main Inclusion Criteria:

          -  Age between 18 and 50.

          -  Single contained symptomatic lesion located on the femoral condyle of the femur graded
             as ICRS III or IV with less than 5 mm of bone loss below the subchondral plate.

          -  Lesion size between 1 and 5 cm2 post debridement, less than or equal to 2.5 cm in
             diameter.

          -  BMI ≤35

          -  Contralateral knee is asymptomatic, stable, fully functional and not medically
             treated.

        Main Exclusion Criteria:

          -  Presence of an additional grade III or IV symptomatic lesion.

          -  Recent Osteochondritis Dissecans within 1 year of baseline visit.

          -  Untreated ACL and/or PCL deficiency or Complex ligamentous instability of the knee.

          -  Patient is excluded if presenting untreated current meniscal tear or if previous
             menisci resection was within the last 6 months.

          -  Previous tendon repair or ligament reconstruction within the last 6 months.

          -  Failed Mosaicplasty or ACI or MACI or any other cartilage repair product.

          -  Microfracture performed less than 1 year before baseline visit.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Brooke Mastrorio</last_name>
    <phone>6094360710</phone>
    <email>bmastrorio@regentis.co.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peninsula Orthopaedic Associates</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <zip>21804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ireland</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2017</study_first_submitted>
  <study_first_submitted_qc>August 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2017</study_first_posted>
  <last_update_submitted>April 9, 2018</last_update_submitted>
  <last_update_submitted_qc>April 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cartilage Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

